Radioisotopes used in nuclear medicine ( 47 Sc, 67 Cu, 68 Ga, 105 Rh, 177 Lu, and 188 Re) were produced by an electron linear accelerator in this study. Neutron irradiation was investigated as an alternative method for producing 105 Rh and 177 Lu, and the results were compared with those obtained with the electron linear accelerator. All the radioisotopes except for 177 Lu were produced efficiently by the electron linear accelerator. Electron linear accelerators were thus demonstrated to show the desired performance for the on-demand production of medical radioisotopes at consuming places such as hospitals.
Introduction
Radioisotopes are used in the diagnosis and treatment of various diseases, including cancer. Diagnosis using radioisotopes improves the therapeutic ratio with early detection of tumors, and radioisotopes realize the treatment of tumors that could not be previously treated. As a result, the demand for medical radioisotopes is increasing. Many of the medical radioisotopes are produced by the fission reaction of highly enriched 235 U in several nuclear reactors around the world. However, it is a global problem that the supply shortage of medical radioisotopes resulting from failure in the transport of them or the shutdown of reactors due to aging. In addition, the use of highly enriched 235 U is restricted from the viewpoint of nuclear nonproliferation.
Methods for radioisotope production using neutrons or protons generated in accelerators have been investigated as alternatives to the abovementioned conventional process [1] [2] [3] . Accelerators are small systems and incur lower construction cost as compared to nuclear reactors. Moreover, accelerators have much lower running cost as compared to nuclear reactors, which require additional expenses due to heavy periodical maintenance checks, compliance with regulations for nuclear reactors, and the large amount of radioactive wastes derived from fission products. In addition, accelerator methods do not require highly enriched 235 U, thus circumventing the problem of nuclear nonproliferation.
An electron accelerator has further advantages for radioisotope production over other accelerators, and its application to radioisotope production has been investigated in past studies [4] [5] [6] [7] [8] . Since the bremsstrahlung photons generated by the electron accelerator have continuous spectrum, multiple radioisotopes can be produced by simply changing the irradiation target without adjusting the beam energy. In our previous study, we produced 99 Mo-99m Tc for single photon emission tomography (SPECT) using an electron linear accelerator and demonstrated the possibility of meeting the demand for 99m Tc [9] . An electron linear accelerator is a lowcost system, but it can be made more cost-effective if it is used to produce not only 99 Mo-99m Tc but also other medical radioisotopes. In this work, the radioisotopes employed in nuclear medicine, 47 Sc, 67 Cu, 68 Ga, 105 Rh, 177 Lu, and 188 Re, were produced in an electron linear accelerator. 105 Rh and 177 Lu were produced using the nuclear reactor by a (n,γ) reaction followed by β − decay to compare the results with those obtained with the electron linear accelerator. Second, the production activity of 67 Cu was compared with the literature value and the value calculated by Monte Carlo simulation. Finally, the production efficiencies when the production system was expanded to a real scale were estimated and discussed with the required activities for diagnosis and treatment.
Experimental

Production by the electron linear accelerator
Radioisotope production was conducted at the electronic linear accelerator of the Institute for Integrated Radiation and Nuclear Science, Kyoto University (KURNS-LINAC). The produced radioisotopes and their nature are listed in Table 1 . nat Ti foil, nat Zn foil, nat Ge powder, nat Pd foil, nat HfC powder, and nat Os powder were prepared for use as irradiation targets. Powdered targets were sealed in a high-purity aluminum foil and shaped into pellets. The details of the target and the generation reaction are shown in Table 2 . These targets were stacked between gold foils (φ10 mm, t0.02 mm) to estimate the fluence of the irradiated photons by using 197 Au(γ,n) 196 Au reaction and sealed in a quartz tube. The target was irradiated with bremsstrahlung photons generated by irradiating 20, 25, 30, 35, 40 MeV electrons to a 2-mmthick Pt converter. The distances between the converter and targets were 10 mm to 15 mm. Irradiation was performed with three sets of targets-nat Ti foil and nat Zn foil, nat Ge pellet and nat Os pellet, nat Pd foil and nat HfC pellet-and each set was irradiated separately. The electron energies, beam currents, and target weights are shown in Table 3 .
Production by the nuclear reactor
The production of 105 
Gamma-ray spectroscopy
The γ rays from 47 Sc (159 keV), 67 Cu (185 keV), 68 Ga (1077 keV), 105 Rh (319 keV), and 177 Lu (208 keV) were measured using a high-purity germanium (HPGe) detector (ORTEC GEM55P4-83). Each irradiated target was placed at an appropriate distance from the surface of the HPGe detector such that the dead time was less than 10%. Measurements were repeated at appropriate intervals to follow the decay curve of the nuclides. The radioactivity of each nuclide was determined using the detection efficiency obtained using a mixed standard source. For determination the activities, the error of detection efficiency and other systematic errors (total 5%) and the counting error were considered.
Results and discussion
Production by the electron linear accelerator
The activities at the end of the irradiation of 47 Sc, 67 Cu, 68 Ga, 105 Rh, 177 Lu, and 188 Re produced by bremsstrahlung photons of 20, 25, 30, 35, 40 MeV electrons at KURNS-LINAC are shown in Table 4 . For 68 Ga, the activities of the parent nuclide 68 Ge at the end of the irradiation are shown because 68 Ge and 68 Ga are in secular equilibrium due to the short half-life of 68 Ga (67.6 min) and long half-life of 68 Ge (271 days). The target weight, beam current, and irradiation time were normalized to 50 mg, 100 μA, and 10 min, respectively. The produced activity increased as the energy of the electrons (E e ) was increased for all nuclides. Table 5 shows the production activities of the 67 Cu by 68 Zn(γ,p) reaction reported by Starovoitova et al. [5] , Yagi and Kondo [4] , and Aliev et al. [8] . Although a strict comparison is not possible because the target shape, converter material, and converter thickness are different and conditions of the electron beam and so on are not necessarily the same, the value at E e = 30 MeV reported by Starovoitova et al. [5] and the value at E e = 30 MeV in this work are consistent. Although the value at E e = 40 MeV using enriched isotopes reported by Yagi and Kondo [4] is 7.1 times the value at E e = 40 MeV in this work, it is consistent considering that the value at E e = 30 MeV using enriched isotopes by Yagi and Kondo [4] is 6.1 times the value at E e = 30 MeV using a natural target reported by Starovoitova et al. [5] . The value at E e = 55 MeV reported by Aliev et al. [8] is greater than the value at E e = 40 MeV in this work, consistent with the result that the produced activity increases as E e is increased.
The produced activity of 67 Cu was calculated using Monte Carlo simulation with the Particle and Heavy Ion Transport code System (PHITS) [10] . The number of photons generated by the converter and the fluence of the photons in the target were calculated using PHITS, and the produced activity was obtained using the calculated fluence and the reaction cross-section of 68 Zn(γ,p) 67 Cu [11] . The calculation 
Production by the nuclear reactor
The activities at the end of the irradiation of 105 Rh and 177 Lu produced by neutron irradiation at KUR were 77 ± 2 kBq and 264.2 ± 0.5 kBq, respectively. These values are normalized to 10 mg, 4.5 × 10 12 n cm −2 s −1 , and 10 min for the target weight, neutron flux, and irradiation time, respectively. In case that the target is thick, it is necessary to correct the self-shielding of neutrons [12] . However, because the targets of this study are thin, the influence of self-shielding is negligible. Table 6 shows the previously reported production activities of 105 Rh and 177 Lu by the same reaction as in this work using nuclear reactors. Although the reactors and targets are different, the values in this work are consistent with the literature data.
Real-scale estimation
The production activities obtained with an electron linear accelerator are estimated when the target weight, beam current, and irradiation time were expanded to real scale. Assuming that the photon fluence is proportional to the beam current, the number of the target atoms is proportional to the target weight, and the reaction cross section is a constant for each reaction, the production activities were estimated using the experimental results. This study demonstrated that electron linear accelerators can effectively produce medical radioisotopes 47 Sc, 67 Cu, 68 Ga, 105 Rh, and 188 Re. The production efficiency of 105 Rh by the electron linear accelerator was comparable to that by the nuclear reactor. For 177 Lu, the production efficiency by the nuclear reactor was higher than by the electron linear accelerator. Thus, further studies on the supply method including neutron irradiation are required.
Conclusions
The activities of 47 Sc, 67 Cu, 68 Ga, 105 On the basis of the experimental values, we estimated the production activities by an electron linear accelerator when the target weight, beam current, and irradiation time were expanded to real scale. Comparison with the required activities for a single diagnosis or treatment indicated that electron linear accelerators are sufficiently capable of producing the medical radioisotopes 47 Sc, 67 Cu, 68 Ga, 105 Rh, and 188 Re. Since electron linear accelerators are more compact and less expensive than nuclear reactors, they are suitable for the on-demand production of medical radioisotopes at consumption places such as hospitals. The linear accelerator system can be made more costeffective by using it for the production of various nuclides such as 47 Sc, 67 Cu, 68 Ga, 105 Rh, and 188 Re in addition to 99 Mo-99m Tc. Table 7 Activities required for a single diagnosis or treatment and estimated production activities when the target weight is 10 g, electron energy is 40 MeV, beam current is 1 mA, and irradiation time is 24 h a Dose of 177 Lu [16] with similar properties as 47 Sc [17] b Therapy for non-Hodgkin's lymphoma [18] c PET imaging for neuroendocrine tumors [19] d Dose of 89 Sr currently used for pain relief in bone metastasis [20] , where the use of 105 Rh is being studied [21] e Therapy for neuroendocrine tumors [16] f Therapy for refractory rheumatoid arthritis [22] Nuclide Required activity for a single diagnosis or treatment/GBq 
